Metabolic syndrome criteria: ready for clinical prime time or work in progress?

Eur Heart J. 2005 Jul;26(13):1249-51. doi: 10.1093/eurheartj/ehi296. Epub 2005 Apr 13.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Coronary Disease / prevention & control*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Metabolic Syndrome / complications*
  • Pravastatin / therapeutic use*
  • Randomized Controlled Trials as Topic

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pravastatin